These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27432210)

  • 21. Left main percutaneous coronary intervention in ACS or stable coronary artery disease: acute and long-term results.
    Varani E; Vecchio S; Aquilina M; Vecchi G; Balducelli M; Frassineti V; Margheri M
    Minerva Cardioangiol; 2016 Feb; 64(1):23-33. PubMed ID: 26989947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presentation, Clinical Profile, and Prognosis of Young Patients With Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): Results From the VIRGO Study.
    Safdar B; Spatz ES; Dreyer RP; Beltrame JF; Lichtman JH; Spertus JA; Reynolds HR; Geda M; Bueno H; Dziura JD; Krumholz HM; D'Onofrio G
    J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29954744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic implications of mean platelet volume on short- and long-term outcomes among patients with non-ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: A single-center large observational study.
    Wasilewski J; Desperak P; Hawranek M; Ciślak A; Osadnik T; Pyka Ł; Gawlita M; Bujak K; Niedziela J; Krawczyk M; Gąsior M
    Platelets; 2016 Jul; 27(5):452-8. PubMed ID: 26939525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of pre-hospital electrocardiograms on time to treatment and one year outcome in a rural regional ST-segment elevation myocardial infarction network.
    Kahlon TS; Barn K; Akram MM; Blankenship JC; Bower-Stout C; Carey DJ; Sun H; Tompkins Weber K; Skelding KA; Scott TD; Green SM; Berger PB
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):245-251. PubMed ID: 27142567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity, Treatment Times, and Cardiovascular Outcomes After ST-Elevation Myocardial Infarction: Findings From Mission: Lifeline North Texas.
    Champagne-Langabeer T; Kim J; Bower JK; Gardner A; Fowler R; Langabeer JR
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of Quality Indicators for Acute Myocardial Infarction in the FAST-MI (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) Registries.
    Schiele F; Gale CP; Simon T; Fox KAA; Bueno H; Lettino M; Tubaro M; Puymirat E; Ferrières J; Meneveau N; Danchin N
    Circ Cardiovasc Qual Outcomes; 2017 Jun; 10(6):. PubMed ID: 28630371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Higher risk of major adverse cardiac events after acute myocardial infarction in patients with schizophrenia.
    Attar R; Wester A; Koul S; Eggert S; Polcwiartek C; Jernberg T; Erlinge D; Andell P
    Open Heart; 2020 Sep; 7(2):. PubMed ID: 32994353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation.
    Niccoli G; Conte M; Marchitti S; Montone RA; Fracassi F; Grippo R; Roberto M; Burzotta F; Trani C; Leone AM; Bianchi F; Di Castro S; Volpe M; Crea F; Rubattu S
    Cardiovasc Revasc Med; 2016; 17(3):162-8. PubMed ID: 26987266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contemporary Revascularization Dilemmas in Older Adults.
    Kumar S; McDaniel M; Samady H; Forouzandeh F
    J Am Heart Assoc; 2020 Feb; 9(3):e014477. PubMed ID: 31973608
    [No Abstract]   [Full Text] [Related]  

  • 30. High triglyceride-glucose index is associated with adverse cardiovascular outcomes in patients with acute myocardial infarction.
    Zhang Y; Ding X; Hua B; Liu Q; Gao H; Chen H; Zhao XQ; Li W; Li H
    Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2351-2362. PubMed ID: 32917496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy.
    Jiménez VA; Iñiguez A; Baz JA; Valdés M; Ortiz A; Vuilliomenet A; Mainar V; Dudek D; Banai S; Tüller D; Bonnet JL; De Miguel A; Bastos G; Wijns W; Saito S
    Cardiovasc Revasc Med; 2016 Sep; 17(6):355-61. PubMed ID: 27156201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trial.
    Jarai R; Dangas G; Huber K; Xu K; Brodie BR; Witzenbichler B; Metzger DC; Radke PW; Yu J; Claessen BE; Genereux P; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2012 Dec; 5(6):813-20. PubMed ID: 23192919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Sex- and Gender-Related Factors on Length of Stay Following Non-ST-Segment-Elevation Myocardial Infarction: A Multicountry Analysis.
    Bender U; Norris CM; Dreyer RP; Krumholz HM; Raparelli V; Pilote L
    J Am Heart Assoc; 2023 Aug; 12(15):e028553. PubMed ID: 37489737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of the SYNTAX score II to predict 1-year outcome in patients with primary percutaneous coronary intervention.
    Wang G; Wang C; Zhang Y; Wang P; Ran C; Zhao L; Han L
    Coron Artery Dis; 2016 Sep; 27(6):483-9. PubMed ID: 27171362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial.
    Arbel Y; Klempfner R; Erez A; Goldenberg I; Benzekry S; Shlomo N; Fisman EZ; Tenenbaum A;
    Cardiovasc Diabetol; 2016 Jan; 15():11. PubMed ID: 26794137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic utility of myocardial blush grade after PCI in patients with NSTE-ACS: Analysis from the ACUITY trial.
    Ng VG; Lansky AJ; Toro S; Parise H; Cristea E; Mehran R; Stone GW
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):215-24. PubMed ID: 25641255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immediate multivessel revascularization may increase cardiac death and myocardial infarction in patients with ST-elevation myocardial infarction and multivessel coronary artery disease: data analysis from real world practice.
    Chung WY; Seo JB; Choi DH; Cho YS; Lee JM; Suh JW; Youn TJ; Chae IH; Choi DJ
    Korean J Intern Med; 2016 May; 31(3):488-500. PubMed ID: 27048252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperglycemia and risk of ventricular tachycardia among patients hospitalized with acute myocardial infarction.
    Tran HV; Gore JM; Darling CE; Ash AS; Kiefe CI; Goldberg RJ
    Cardiovasc Diabetol; 2018 Oct; 17(1):136. PubMed ID: 30340589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining the prognosis of chronic total occlusions during primary percutaneous coronary intervention.
    Şen Ö; Şen F; Topuz M; Allahverdiyev S; Baykan AO; Akkuş O; Sümbül Z; Çaylı M
    Coron Artery Dis; 2016 May; 27(3):207-12. PubMed ID: 26863599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Simple Risk Stratification Model for ST-Elevation Myocardial Infarction (STEMI) from the Combination of Blood Examination Variables: Acute Myocardial Infarction-Kyoto Multi-Center Risk Study Group.
    Yanishi K; Nakamura T; Nakanishi N; Yokota I; Zen K; Yamano T; Shiraishi H; Shirayama T; Shiraishi J; Sawada T; Kohno Y; Kitamura M; Furukawa K; Matoba S
    PLoS One; 2016; 11(11):e0166391. PubMed ID: 27835698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.